Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Organos Inc
Profile last edited on: 2/26/2021      CAGE: 7PQ49      UEI: FFLFTZBQW3H8

Business Identifier: Analysis of action potential and calcium transient dynamic in cardiac MPS to predict arrhythmia
Year Founded
2016
First Award
2020
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

3841 Campolindo Drive
Moraga, CA 94556
   (925) 818-6312
   organosinc@icloud.com
   N/A
Location: Single
Congr. District: 11
County: Contra Costa

Public Profile

Oreganos is a biotech. medical device start-up developing tissue on a chip technology. The chip is designed to enables scientists to see how the heart tissue reacts to specific drugs that are injected into the enclosed system. The effort is designed to disrupt and expedite the FDA drug trial market by mitigating excess spend on drugs that fail before clinical trials.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
2
Conversion Rate
100.00%
Phase I Dollars
$925,512
Phase II Dollars
$1,159,994
Total Awarded
$2,085,506

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 2 NIH $974,212
Project Title: High-throughput Human Micro-Heart Muscle for Drug Discovery
2021 2 NIH $1,462,625
Project Title: Combined Computational and Cardiac Microphysiological System Approach for Drug-Induced Proarrhythmia Screening

Key People / Management

  Kevin Healy -- President

  Abheshek Gupta -- Business Analyst

  Brian Siemons -- Scientist/Technician

  Samuel T Wall -- Founder and CSO

  Mark Warren -- Senior Research Scientist

Company News

There are no news available.